Endometrial cancer

  • Home
  • Endometrial cancer

Endometrial cancer, also known as uterine cancer, originates in the lining of the uterus (the endometrium). It is the most common cancer of the female reproductive system.

Types:

  1. Endometrioid Adenocarcinoma: The most common type, typically linked to hormone levels.
  2. Serous Carcinoma: More aggressive and often diagnosed at a later stage.
  3. Clear Cell Carcinoma: A less common but aggressive form.
  4. Uterine Sarcomas: These develop from the muscle or connective tissue of the uterus and are rare.

Risk Factors:

  • Age: Most cases occur in women over 50, especially postmenopausal women.
  • Obesity: Excess body fat increases estrogen levels, a significant risk factor.
  • Hormonal Imbalance: Conditions like polycystic ovary syndrome (PCOS) and estrogen replacement therapy without progesterone can elevate risk.
  • Family History: A history of uterine, breast, or colorectal cancers may increase risk.
  • Diabetes and Hypertension: Associated with higher risk of endometrial cancer.

Symptoms:

  • Abnormal Vaginal Bleeding: Especially after menopause or between periods.
  • Pelvic Pain: Discomfort or pain in the pelvic region.
  • Unusual Discharge: Watery or blood-stained discharge not related to menstruation.
  • Changes in Bowel Habits: Occasionally, may experience changes like constipation.

Diagnosis:

  • Pelvic Examination: A thorough examination to check for abnormalities.
  • Ultrasound: Transvaginal ultrasound can help assess the endometrial lining.
  • Endometrial Biopsy: A definitive diagnosis is often made through biopsy, where a sample of the endometrium is taken for analysis.
  • Hysteroscopy: A procedure to directly visualize the inside of the uterus and obtain biopsies.

Treatment:

  1. Surgery: The primary treatment often involves a hysterectomy (removal of the uterus) and possibly removal of the ovaries and fallopian tubes.
  2. Radiation Therapy: Used post-surgery or for advanced cases to kill remaining cancer cells.
  3. Chemotherapy: May be considered for advanced or recurrent cancer.
  4. Hormonal Therapy: Can be effective for hormone receptor-positive tumors.

Prognosis:

The prognosis for endometrial cancer is generally good, particularly when diagnosed early. The five-year survival rate for localized endometrial cancer is quite high, but it decreases for more advanced stages.

Prevention:

  • Maintain a Healthy Weight: Reducing obesity can lower risk.
  • Regular Check-ups: Annual gynecological exams can help with early detection.
  • Manage Hormonal Health: Discuss hormonal treatments with a doctor if you have conditions that affect estrogen levels.
  • Oral Contraceptives: Long-term use of birth control pills has been associated with a reduced risk.